Search results for " name" in Articles / App Notes
								 					Article
				
				What’s In a Name? For Biosimilars, A Lot
								Naming for small-molecule drugs 
	
	BioPharm: What is current practice for small-molecule generic drugs in terms of a product’s name and its monograph? How do monograph and name typically relate? 
	…								
								 					Article
				
				FDA Urged to Preserve Biosimilar Naming Conventions
								
	The Generic Pharmaceutical Association (GPhA) is reporting that 32 organizations, including pharmacies and labor unions, have signed a letter urging FDA to require biologics and biosimilars to have …								
								 					Article
				
				FDA Approves First Biosimilar
								For now, FDA is using a “placeholder” nonproprietary name—filgrastim-sndz—to identify the product, but the agency does not mean for this to indicate it has made a decision on a comprehensive naming po…								
								 					Article
				
				mAbs to Watch in 2016
								Obiltoxaximab—Elusys Therapeutics’ mAb, obiltoxaximab, which will go by the trade name Anthim, differs significantly from the rest of the mAb pack. The investigational agent for the treatment of inhal…								
								 					Article
				
				N-Glycan Analysis of Biotherapeutic Proteins
								What’s in a (glycan) name? 
	To inexperienced researchers, an initially intractable idiosyncrasy of N-glycan analysis is the number of N-glycan nomenclatures in current use. This can complicate inte…								
								 					Article
				
				Biosimilars to Drive Modern Manufacturing Approaches
								
	Reliable, high-quality products require innovative analytics and production. 
	By Jill Wechsler 
	As more biosimilars gain market approval in the United States, and manufacturers launch addition…								
								 					Article
				
				Digitalization: The Route to Biopharma 4.0
								Digitalization in process development
	
		For any production process, there are two key attributes, namely scientific knowledge and technical know-how. Scientific knowledge comprises process developme…								
								 					Article
				
				Gene Therapies Push Viral Vector Production
								In general, there are two types of gene therapies, namely ex-vivo and in-vivo, Chaudhary points out. “In ex-vivo, cells are modified outside the patient’s body and the corrected version is transplante…								
								 					Article
				
				Mechanistic Modeling of Preparative Ion-Exchange Chromatography
								Broadly, there can be four boundaries for mass transfer limitations at the bead level, namely, external mass transfer through the film layer (kfilm) around the bead particle, diffusion through the por…								
								 					Article
				
				An Integrated Approach to Ensure the Viral Safety of Biotherapeutics
								Viral testing/detection level 
				
				
					As the name indicates, the main purpose of this level is to detect adventitious viruses. Early detection is essential in order to deploy an adequate respo…